Skip to main content
SpringerLink
Log in

Interstitial Lung Disease in Patients with Hepatopulmonary Syndrome: A Case Series and New Observations

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Hepatopulmonary syndrome (HPS) is characterized by impaired oxygenation due to pulmonary vascular dilatation in patients with end-stage liver disease. At our center, we identified 29 patients who were listed for liver transplantation (LT) with a model for end-stage liver disease exception for HPS between 2001 and 2012. Five of these patients were found to have concurrent interstitial lung disease (ILD). The chest high-resolution computed-tomography demonstrated ground-glass opacities and subpleural reticulation, most consistent with nonspecific interstitial pneumonia (NSIP). All four of our patients who underwent LT experienced prolonged hypoxemia postoperatively, with one surgery-related death. However, the three surviving patients had eventual resolution of their hypoxemia with no evidence of ILD progression. In conclusion, we report a high prevalence of ILD, most consistent with NSIP, among patients with HPS. Although there may be increased perioperative risks, the finding of ILD in patients with HPS should not be considered an absolute contraindication to LT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Arguedas MR, Singh H, Faulk DK, Fallon MB (2007) Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol 5(6):749–754

    Article  PubMed  Google Scholar 

  2. Lima BL, Franca AV, Pazin-Filho A et al (2004) Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 79(1):42–48

    Article  PubMed  Google Scholar 

  3. Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C (2003) Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125(4):1042–1052

    Article  PubMed  Google Scholar 

  4. Fallon MB, Krowka MJ, Brown RS et al (2008) Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology 135(4):1168–1175

    Article  PubMed Central  PubMed  Google Scholar 

  5. Collisson EA, Nourmand H, Fraiman MH et al (2002) Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl 8(10):925–931

    Article  PubMed  Google Scholar 

  6. Deberaldini M, Arcanjo AB, Melo E et al (2008) Hepatopulmonary syndrome: morbidity and survival after liver transplantation. Transpl Proc 40(10):3512–3516

    Article  CAS  Google Scholar 

  7. Taille C, Cadranel J, Bellocq A et al (2003) Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 75(9):1482–1489 discussion 1446-1487

    Article  PubMed  Google Scholar 

  8. Murray KF, Carithers RL Jr (2005) AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 41(6):1407–1432

    Article  PubMed  Google Scholar 

  9. Mercer PF, Chambers RC (2013) Coagulation and anticoagulation signaling in fibrosis. Biochim Biophys Acta 1832:1018–1027

    Article  CAS  PubMed  Google Scholar 

  10. Liu L, Liu N, Zhao Z et al (2012) TNF-α neutralization improves experimental hepatopulmonary syndrome in rats. Liver Int 32(6):1018–1026

    Article  CAS  PubMed  Google Scholar 

  11. Zhang J, Luo B, Tang L et al (2009) Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology 136(3):1070–1080

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Keane M, Strieter R, Lynch P, Belperio J (2006) Inflammation and angiogenesis in fibrotic lung disease. Sem Respir Crit Care Med 27(6):589–599

    Article  Google Scholar 

  13. Kapanci Y, Desmouliere A, Pache JC, Redard M, Redard M, Gabbiani G (1995) Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. Am J Respir Crit Care Med 152:2163–2169

    Article  CAS  PubMed  Google Scholar 

  14. Michel RP, Stewart DJ, Sheppard M, Hamid Q, Corrin B (1993) Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 341(8860):1550–1554

    Article  PubMed  Google Scholar 

  15. Swanson KL, Wiesner RH, Krowka MJ (2005) Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology 41(5):1122–1129

    Article  PubMed  Google Scholar 

  16. Gupta S, Castel H, Rao RV et al (2010) Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transpl 10(2):354–363

    Article  CAS  Google Scholar 

  17. Krowka MJ, Mandell MS, Ramsay MA et al (2004) Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 10(2):174–182

    Article  PubMed  Google Scholar 

  18. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB (2003) Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37(1):192–197

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Pulmonary and Critical Care, University of California, Los Angeles, Westwood, USA

    S. Shahangian, M. Y. Shino, I. Barjaktarevic, I. Susanto, J. A. Belperio, M. C. Fishbein & T. Wang

Authors
  1. S. Shahangian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Y. Shino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Barjaktarevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Susanto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. A. Belperio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. C. Fishbein
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Shahangian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shahangian, S., Shino, M.Y., Barjaktarevic, I. et al. Interstitial Lung Disease in Patients with Hepatopulmonary Syndrome: A Case Series and New Observations. Lung 192, 421–427 (2014). https://doi.org/10.1007/s00408-014-9571-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-014-9571-z

Keywords

Search

Navigation